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Mice deficient for interferon regulatory factor (IRF)-2 (IRF2-/- mice) exhibit immunological 
abnormalities and cannot survive lymphocytic choriomeningitis virus (LCMV) infection. The 
pancreas of these animals is highly inflamed, a phenotype replicated by treatment with poly(I:C), a 
synthetic double-stranded RNA. Trypsinogen5 mRNA was constitutively up-regulated about 
1,000-fold in IRF2-/- mice compared to controls, as assessed by qRT-PCR. Further knockout of the 
IFN receptor 1 (IFNAR1) abolished the poly(I:C)-induced pancreatitis, but had no effects on the 
constitutive up-regulation of trypsinogen5 gene, indicating crucial type I IFN (I-IFN) signaling to 
elicit the inflammation. Analysis of IFNAR1-/- mice confirmed I-IFN-dependent transcriptional 
activation of dsRNA-sensing pattern recognition receptor genes, MDA5, RIG-I, and TLR3, which 
induced poly(I:C) dependent cell death in the acinar cells, in the absence of IRF2. We speculate that 
Trypsin5, the trypsinogen5 gene product, leaking from the dead acinar cells, triggers a chain reaction 






Interferons (IFNs) are cytokines whose actions contribute to the first line of defense against 
infection. IFNs both render cells resistant to viral attack and regulate cell growth and differentiation 
(1). IFNs elicit their pleiotropic effects by regulating the expression of many interferon-stimulated 
genes (ISGs). IFNs themselves are controlled by interferon regulatory factors (IRFs) that also 
regulate the expression of ISGs. By binding to interferon-stimulated response elements (ISREs) in 
gene promoters, the nine known IRF family members (IRF1-9) govern the production of cytokines 
related to inflammation and immune responses.  
When pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and retinoic 
acid-inducible gene-I (RIG)-like receptors (RLR) detect pathogen ligands, these receptors are 
activated (2) and transduce downstream signaling activating IFNs and IRFs. Analyses using 
knockout (KO) mice deficient for various IRFs have revealed their physiological roles. For example, 
IRF2 functions mainly as a transcriptional repressor by competing for binding to ISREs with other 
IRFs, especially IRF9 and IRF1 (1).  
IRF2-deficient (IRF2-/-) mice spontaneously develop inflammatory skin disease as they age, 
and die within weeks with lymphocytic choriomeningitis virus (LCMV) infection (3). Ablation of 
IFN receptor1 (IFNAR1) or IRF9 ameliorates the skin inflammation of IRF2-/- mice, suggesting 
that IRF2 negatively regulates gene expression by antagonizing IRF9, which is activated by type I 
IFN (I-IFN) (4). However, the precise mechanisms underlying the phenotypes of IRF2-/- are not 
known. In this study, we found that poly(I:C)(pIC) mimicked the LCMV-induced pancreatitis, and 
4 
 
we have used double KO mice to explore the cause of death in pIC-treated IRF2-/- mice. Our results 
show that significant trypsinogen5 up-regulation in IRF2-/- mice together with I-IFN-dependent 
transcriptional activation of dsRNA-sensing PRRs were critical for the pIC-induced death. 
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Results and Discussion  
IRF2-/- mice show IFN-dependent poly(I:C)-induced pancreatitis and IFN-independent 
secretory dysfunction in pancreatic acinar cells.  
LCMV-infected IRF2-/- mice die within four weeks post-infection (3), but all IRF2-/- mice 
challenged intraperitoneally (i.p.) with poly(I:C) (pIC-IRF2-/- mice) died within one week (Fig.1A). 
Severe acute pancreatitis was apparent in pIC-IRF2-/- mice, as shown by abundant TUNEL+ 
apoptotic cells (Fig.1B). Even in the absence of pIC, however, some abnormalities were detected in 
IRF2-/- pancreas as indicated by hematoxylin and eosin (HE) staining (Fig.1C) and electron 
microscopy (Fig.1D) A mild infiltration of inflammatory cells (particularly lymphocytes) was noted 
around IRF2-/- ductal cells, but this pancreatitis was not typical. The pancreatic acinar cells in 
untreated IRF2-/- mice were filled with eosinophilic secretory granules of heterogeneous size, 
whereas fewer eosinophilic granules of more uniform size were observed mainly in the apical region 
of WT acinar cells. Interestingly, treatment of IRF2-/- mice with the stable cholecystokinin (CCK) 
analogue cerulein (5) did not cause acute pancreatitis, as assessed by electron microscopy and serum 
amylase levels (Fig.S1A,B). Because mRNA expression of CCK receptors in IRF2-/- mice was 
normal (Fig.S1C), these results suggest that the secretory and/or vesicle transport systems in IRF2-/- 
mice are dysfunctional. 
The mRNAs encoding the Ca2+-binding proteins Anxa10, Ahsg, and S100-G involved in 
Ca2+-dependent vesicle transport, sorting and fusion processes, were significantly up-regulated in 
IRF2-/- pancreas (Table S1). The secretory dysfunction observed in cerulein treated IRF2-/- mice (6), 
6 
 
which is due to an abnormal distribution pattern of normal levels of soluble 
N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) (6) may be due to the 
abnormal expression of these Ca2+-binding proteins in the absence of IRF2 since annexin family 
proteins are known to bind and regulate of (SNAREs) (7).   
Skin inflammation in IRF2-/- mice was rescued by abolishing IFN signaling (4). We asked if 
the atypical pancreatitis in IRF2-/- mice could be similarly rescued by crossing the IRF2-/- mutants to 
IFNAR1-, IRF1-, or TRIF-deficient mice (3, 8, 9) to generate double knock-out (DKO) mice. 
Abnormal acinar granule distribution was again observed in IRF2-/-IFNAR1-/-, IRF2-/-IRF1-/-, and 
IRF2-/-TRIF-/- mice (Fig. 1D). Thus, the abnormal acinar structure caused by Irf2 disruption is not 
mediated by IFN signaling. 
To assess pancreatitis in the DKO mice, we measured serum amylase levels before and after 
pIC challenge (Fig.1E). Serum amylase was elevated in pIC-IRF2-/- and pIC-IRF2-/-IRF1-/- mice. 
However, this increase did not occur at all in pIC-IRF2-/-IFNAR1-/- mice, and only to a limited extent 
in pIC-IRF2-/-TRIF-/- mice. These data indicate that type I IFN signaling via IFNAR1, as well as TLR 
signaling via the adaptor protein TRIF, are important for the development of pIC-induced 
pancreatitis in IRF2-/- mice. Moreover, our results show that IRF2 regulates IFN-independent 






Up-regulated trypsinogen5 mRNA in the pancreas of IRF2-/- mice 
We used an Affymetrix DNA microarray system to compare mRNA expression in the 
pancreas before and after pIC injection of IRF2-/- and WT mice (Fig. 2A). In IRF2-/- mice, 14 
annotated genes were up-regulated and 8 genes were down-regulated more than 10-fold (Table S1) 
compared to WT mice. The transcriptional profiles of genes important for the etiology of pancreatitis 
(10, 11) are listed in Table 1. Strikingly, trypsinogen5 mRNA was up-regulated >100-fold in 
pIC-IRF2-/- pancreas, a noteworthy observation because trypsinogens activate many other pancreatic 
enzymes, and premature intracellular activation of trypsinogens in pancreatic acinar cells triggers 
acute pancreatitis (10, 11). There are 20 trypsinogen genes (T1-T20) in the murine T cell receptor  
gene locus (12), 12 of which express trypsinogen proteins (Fig.S2 right) while humans have only 3 
trypsinogen genes encoding three proteins: PRSS1, PRSS2, and PRSS3 (Fig.S2 left) (13). The gene 
expression profile of pIC-IRF2-/- pancreas is inflammation-prone: mouse trypsinogen mRNAs of T11 
(Prss3), and T4 (Trypsinogen5) were up-regulated (Table 1), the mRNA encoding cysteine protease 
cathepsin B (Ctsb), an enzyme that can initiate pancreatitis by activating trypsinogens (14-16), was 
also up-regulated (Table 1). The mRNA encoding chymotrypsin C (Ctrc) was down-regulated, and 
the anti-pancreatitis factor, inter -trypsin inhibitor, was also down-regulated, although the mRNA 
encoding Kazal type3 (Spink3), a serine protease inhibitor that blocks trypsin activity (17), was 
slightly up-regulated 
We examined the tissue specificity and dependency on IRF2 and IFNAR1 of trypsinogen5 
expression by quantitative RT-PCR. In untreated WT mice, trypsinogen5 is expressed most highly in 
8 
 
pancreas and skin, and modestly in spleen (Fig.S3A). In untreated IRF2-/- mice, trysinogen5 
expression in the pancreas was up-regulated ~1,000-fold compared to controls, and was not affected 
by IFNAR1 ablation. Trypsinogen5 mRNA was up-regulated in IRF2-/- spleen to a much lower extent 
than in IRF2-/- pancreas, and was not detectable in liver or lung of WT or IRF2-/- mice.  
We examined the effects of various IRFs on the activity of the murine trypsinogne5 
promoter which contains 7 ISREs. We cloned a 1.1kb fragment of the trypsinogen5 promoter region 
(-1063 to +15), to create a series of promoter deletion constructs mutants, driving the firefly 
luciferase reporter gene (Fig.2B left). These were transfected into HEK293T cells along with 
plasmids overexpressing murine IRF1, IRF5, IRF7 or MyD88. MyD88 was required for 
IRF-mediated activation of trypsinogen5 ISREs, and significant promoter activity was observed 
when IRF1, IRF5 or IRF7 was overexpressed (Fig.S3B). Furthermore, the -216 to +15 promoter 
region of trypsinogen5 was sufficient for responses to IRF1 or IRF7 stimulation (Fig. S3C). 
Overexpression of IRF2 inhibited IRF1- or IRF7-stimulated promoter activity in a dose-dependent 
manner (Fig S3D). These data suggest that IRF2 binds to the proximal promoter of trypsinogen5 and 
inhibits the access of IRF1, IRF5 and IRF7 to ISRE sites in this region. 
To confirm this hypothesis, we transfected TGP49 cells, a mouse acinar cell line, with the 
trypsinogen5 promoter deletion series reporters as well as plasmids expressing IRF1, 5 or 7, and  
assessed the promoter activities (Fig.2B right). The basal promoter activity was drastically decreased 
by deleting the -216 to -100 containing two ISREs, a nuclear factor activated T cell (NFAT), and an 
activator protein-1 (AP-1) binding sites. In contrast to 293T cells, the trypsinogen5 promoter in 
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TGP49 cells could be activated by exogenously-expressed IRF5 or IRF7 without MyD88 (Fig.3A). 
The promoter could not be activated by IRF1 even in the presence of MyD88 expression. The 
regions responsive to IRF5 and IRF7 were confirmed to be ISRE4 (-62 to -59) and ISRE3 (-55 to 
-49) by site-specific mutation analysis (Fig.2C). The IRF5- and IRF7-dependent promoter activities 
were significantly (p<0.05) enhanced by knocking-down IRF2 with specific siRNA compared to 
control (scrambled) siRNA (Fig.3A). 
To confirm IRF2 binding to the proximal promoter of trypsinogen5 in pancreatic acinar cells 
in vivo, we performed chromatin immunoprecipitation (ChIP) assays in TGP49 cells using specific 
PCR probes spanning all seven ISREs (-173 to +56) in the trypsinogen5 promoter. Anti-IRF2 
antibody (Ab) specifically precipitated the trypsinogen5 promoter, as determined by 
semi-quantitative PCR (Fig.3B) and real-time PCR (Fig.3C). These results suggest that in WT mice, 
trypsinogen5 expression in pancreatic acinar cells is repressed by the binding of IRF2 to ISREs in the 
proximal promoter region. However, in IRF2-/- mice, the trypsinogen5 gene is activated because 
IRF5 and IRF7 can access the ISREs in the absence of IRF2.  
IRF5 and IRF7 are critical inducers of the expression of proinflammatory cytokines and 
type I IFNs, respectively (18,19), and these activities require MyD88. In WT cells, IRF4 inhibits 
IRF5 function by sequestering MyD88 (18). IRF-2 did not associate with MyD88 (18), but in our 
study, it did bind to the ISRE-containing region in the trypsinogen5 promoter (Fig.3B,C). Therefore, 
we postulate that IRF-2 inhibits IRF5 and IRF7 activity by competing with them for binding to 
ISREs, rather than by sequestering MyD88.  
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Trypsinogen5 is resistant to the trypsin inhibitor Spink3 
Comparison of mouse trypsinogen5 to other mouse and human trypsinogens (Fig.S4) showed that, 
although the N-terminal activation peptide sequence (NSDDK-I) in trypsinogen5 differs from that in 
other trypsinogens (DDDDK-I), other important regions, including the triad amino acid sequence, 
H-D-S, required for enzymatic activity, are conserved (10,11). In addition, tryptic activity in cell 
lysates of 293FT cells overexpressing trypsinogen5 was dramatically enhanced by treatment with 
enteropeptidase (EP) (Fig.4A,B). The trypsinogen5 inhibitor binding site (DSCDGDS), which 
prevents premature activation, differed from that found in most trypsinogens (DSCQGDS) (10,11), 
resembling the inhibitor binding site (DSCQRDS) of the human trypsin inhibitor-resistant PRSS3 
enzyme. In addition, the trypsin autocatalytic cleavage site (Q-V) in trysinogen5 differed from that in 
other trypsinsogens (R-V), suggesting that trypsinogen5 is resistant to both trypsin inhibitors and 
self-inactivation. Indeed, trypsinogen5 was resistant to inhibition by Spink3, a major endogenous 
trypsin inhibitor in mice (Fig.4C,D), as well as soy bean trypsin inhibitor (SBTI) (Fig.S5A,B). 
Analysis of the evolutionary pedigree in Fig.S6 showed that mouse trypsinogen5 is most distant from 
mPrss1 and mPrss2, just as human PRSS3 is most distant from PRSS1 and PRSS2. Therefore, we 
believe that mouse trypsinogen5 is a homologue of human PRSS3. Moreover, our data suggest that, 
in the absence of IRF2, trypsinogen5 is highly expressed and exacerbates pIC-induced pancreatitis 




Poly(I:C)-induced cell death can be triggered by a TLR3/TRIF-dependent pathway or a 
RIG-I/MDA5/IPS-1-dependent pathway 
 Although trypsinogen5 was up-regulated in untreated IRF2-/- mice, only mild inflammation 
around acinar cells was observed and pancreatitis did not occur. We hypothesize that trypsinogen5 as 
well as mPrss1, 2, and 3 leaking from dying acinar cells, is activated by proteases such as cathepsin 
B or enteropeptidase, also released from these cells. These activated trypsins trigger signals to induce 
the death of many acinar cells, a process of cell death amplification we refer to as the “enhancing 
loop” of acinar cell death. In this way, the initial death of a few cells induced by pIC can precipitate 
severe pancreatitis. This idea is supported by a report that the extracellular or intracellular treatment 
of pancreatic acinar cells with active trypsins causes acinar cell death (20). In this study, the 
enteropeptidase-cleavage site (-DDDDK-) of rat trypsinogen was replaced with a cleavage site 
(-RTKR-) recognized by paired basic amino acid cleaving enzyme (PACE). This allowed the rat 
trypsinogen to be activated intracellularly with the ubiquitously expressed PACE enzyme rather than 
with enteropeptidase, which is expressed mainly in the duodenum. We created a PACE-trypsinogen5 
enzyme, which successfully induced the apoptosis of 293FT cells when overexpressed (Fig.4E,F). 
These results indicate that proteolytic activation of trypsinogen5 is sufficient to induce for cell death. 
Since pIC-dependent pancreatitis in IRF2-/- mice can be prevented by inactivating IFNAR1 
signaling (Fig.1E), we focused on IFN signaling pathways to identify candidates which might trigger 
initial cell death following pIC treatment. Indeed, IRF1, IRF7, MyD88, MDA5, RIG-I, and TLR3 
gene expression were all up-regulated in the pancreas of pIC-IRF2-/- mice (Table S2). Because these 
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proteins are associated with the cell death pathways dependent on TRIF or IPS-1, we examined the 
effect of IRF2 loss on these well characterized systems (21,22). TRIF binds to receptor-interacting 
proteins (RIPs) and thereby activates caspase8 via FADD to induce cell death (21), whereas the 
IPS-1-dependent cell death pathway, which is triggered by MDA5 or RIG-I, is reported to activate 
caspase9 via the mitochondrial pathway dependent on Apaf-1 and cytochrome c (22). We confirmed 
that 293FT cells transfected with TRIF-expressing plasmid underwent apoptosis, as shown by 
staining with FITC-labeled annexin V (Fig.5B). Next, we employed the MTT viability assay to 
quantify the extent of cell death induced by IFN-related molecules in the presence or absence of pIC 
and IFN. Exogenous overexpression of IPS-1 or TRIF significantly enhanced the death of pIC- and 
IFN-treated 293FT cells, and the death-inducing effects of MDA5 and RIG-I were enhanced by 
co-transfection with IPS-1 (Fig.5A). These results suggest the existence of at least two 
pIC-dependent cell death pathways: one TLR/TRIF-dependent, and one 
RIG-I/MDA5/IPS-1-dependent. 
We used real-time PCR to examine the induction of TLR3, RIG-I and MDA5 mRNAs in 
pIC-treated WT, IRF2-/-, and IRF2-/-/IFNAR1-/- mice. The levels of all three mRNAs were induced by 
nearly 100-fold in both pIC-WT and pIC-IRF2-/- mice, and these increases were abolished by 
deletion of IFNAR1 (Fig.5C-E). As shown in Fig.6 and Table S3, the IFN signal activation triggered 
by pIC is essential to initiate the TLR/TRIF- and RIG-I/MDA5/IPS-1-dependent acinar cell death, 
but is not sufficient to cause pancreatitis. The elevation of trypsinogen5 expression mediated by 
abolishing IRF2, is also necessary for enhancing the cell death leading to the lethal pancreatitis. 
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Activation mechanisms of mouse trypsinogen5 and human PRSS3 
Trypsinogens (including trypsinogen5) can be activated in pancreatic acinar cells, or in other 
cells or tissues by enteropeptidase expressed in non-duodenal cells (23), such as in keratinocytes and 
oral carcinoma cells (24,25). It is possible that keratinocyte-expressed enteropeptidase activates the 
trypsinogen5 expressed in skin (Fig.S3A), promoting age-dependent skin inflammation in IRF-2-/- 
mice (4). Another possibility could be that proteases in addition to enteropeptidase can cleave 
pancreatic trysinogen5. We have confirmed that cathepsin B, whose expression was elevated in 
IRF2-/- mice, can activate trypsinogen5 in vitro (Fig. S5C). The last possibility is that autocatalytic 
cleavage of trypsinogen, usually restricted under steady-state conditions, is accelerated in response to 
a chemical stress or viral infection. Indeed, the auto-activation of trypsinogen is reportedly 
accelerated in low pH or by Ca2+ in vitro (26). 
In conclusion, this study has identified important genes associated with IRF2 functions in 
mice. Our results suggest that IRF2 influences the expression of mouse trypsinogen5, whose human 
counterpart is PRSS3. Our data should therefore help to elucidate new IRF functions in humans. 
14 
 
Materials and Methods 
Mice 
 IRF1-/-, and IRF2-/- mice have been described (3). IFN- receptor 1 (IFNAR1)-/- mice 
were purchased from B&K Universal (8).  TRIF-/- mice have been described (9).  
IRF-2-/-IFNARI-/-, IRF-2-/-/IRF1-/-, and IRF-2-/-/TRIF-/- double mutant mice were generated by 
crossing IRF-2+/-, with IFNAR1-/-, IRF1-/-, and TRIF-/- mice, respectively. All mice were maintained 
under specific pathogen-free conditions and used at 6-12 week of age. All experiments were 
performed according to institutional guidelines.  
Cells 
Human embryonic kidney (HEK) 293T and 293FT (Invitrogen) cells, and HeLa cells were 
cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum.  
Mouse pancreatic acinar TGP49 cells were cultured in 1:1 mixture of Dulbecco’s modified Eagle’s 
medium and Ham’s F12 medium supplemented with 10% fetal bovine serum. 
Histological analysis 
 The pancreas tissues were fixed overnight in 10% formalin, embedded in paraffin, 
sectioned, and stained with hematoxylin (0.4%) and eosin (0.5%) for light microscopic analysis.  
For electron microscopic analysis, the tissues were fixed in 2.5% glutaraldehyde solution buffered to 
pH 7.4 with 0.1M phosphate buffer for 4h at 4°C. Postfixation was performed with 2% osmium 
tetroxide solution buffered to pH 7.4 with the same buffer for 2h at 4°C, and they were embedded, 




 Total RNAs from the pancreas of wild type and IRF2-/- mice aged 6 weeks, harvested 3h 
after no injection or a peritoneal injection with 250 g poly(I:C), were used in the array studies.  
The quality of the RNA was assessed with an Agilent 2100 Bioanalyzer, and samples of 100 ng total 
RNA were reverse transcribed and then amplified in vitro transcription according to Affymetrix 
standard protocols. The mouse Affymetrix GeneChip Mouse Gene 1.0 ST Array was used in all 
hybridizations. These arrays contain probes representing transcripts for 28,815 mouse gene entities.  
Microarray data were analyzed using the Affymetrix Expression Console Software, and Gene Spring 
GX, whereas differentially expressed genes were identified with annotation. 
Real-time RT-PCR 
 Total RNA was prepared from tissues using the acid phenol-guanidinium thiocyanate 
method, after immersing the tissues for more than overnight in RNA Later solution (Ambion). 
Reverse transcription was conducted for 60min at 46°C from 200 ng of purified total RNA using 
Superscript III (Invitrogen), followed by 45 cycles of PCR (15s denaturation at 95°C, 25s annealing 
at 55°C and 15s extension at 72°C). A SYBR Green PCR kit (Qiagen) was used to monitor the PCR 
products on the LightCycler 1.5 and real-time PCR detection system (Roche). Primers designed for 
respective genes are listed in Table S5. 
Plasmid constructs 
 The cDNA encoding human IRF1, IRF7, and IPS-1 were generated from total RNA 
prepared from 293T cells by RT-PCR, using KOD-FX DNA polymerase (TOYOBO). The human 
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MDA5, RIG-I, and TLR3 cDNAs were generated from total RNA prepared from THP-1 (a human 
leukemia cell line), or HeLa cells by RT-PCR. The mouse Trypsinogen5, Prss1, and Spink3 cDNAs 
were made from total RNA prepared from WT mouse pancreas by PCR. All constructs generated by 
PCR were confirmed by DNA sequencing. The pTrypsinogen5-Luc reporter plasmid was constructed 
by inserting the promoter region (-1063 to +15) of the mouse trypsinogen 5 gene by PCR into the 
pGL2-Basic vector. A series of deletion mutants were made using proper restriction enzymes (NcoI 
at -833; SpeI at -579; ScaI, at -386; PvuII at -216), and a specific primer for -100 site. The promoter 
region (-216 to +15) of the mouse trypsinogen 5 gene was used to introduce point mutations into the 
ISREs. The point mutations of the ISRE3 (-55 to-49, ATTGAAA→GTTTGCG), ISRE4 (-62 to-59, 
TTTC→CGCA), and ISRE5 (-84 to-78, AATGAAA→GATTGCG) were introduced by overlap PCR 
mutagenesis. All constructs generated by PCR were confirmed by DNA sequencing. 
 The PACE-Trypsinogen5 was constructed replacing the activation peptide (-NSDDK-) of 
the mouse trypsinogen5 cDNA with the PACE recognition peptide (-RTKR-), by overlap PCR 
mutagenesis. 
Luciferase reporter assay 
 293T cells (1x105/well) were plated in 24-well plates, and transfected 24h later with 200 ng 
of the firefly luciferase reporter plasmid pTrypsinogen5-Luc, using FuGENE6 (Roche), along with 
each expression vector (20 ng unless otherwise stated) as indicated. In all cases, cells were 
transfected with 20 ng pRL-TK (thymidine kinase promoter-driven Renilla luciferase reporter gene, 
Promega), to normalize the transfection efficiency. TGP49 cells (1x105/well) were plated in 12-well 
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plates, and transfected 24h later with 1 g of the firefly luciferase reporter plasmid 
pTrypsinogen5-Luc, using Lipofectamine 2000 (Invitrogen), along with each expression vector (100 
ng unless otherwise stated) as indicated. In all cases, cells were transfected with 20 ng pRL-RSV 
(RSV promoter-driven Renilla luciferase reporter gene). At 26h post-transfection, the luciferase 
activity was determined with the dual luciferase assay system. The mouse IRF2-specific and control 
siRNAs were purchased from Santa Cruz. 
Chromatin immunoprecipitation (ChIP) 
The nuclear extracts from TGP49 cells were subjected to DNA-protein cross-linking with 1% 
formaldehyde for 5min. After extensive washing, the samples were suspended in 500 μl of 150 mM 
NaCl, 25 mM Tris, pH 7.5, 5 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.5% deoxycholate, and 
were sonicated. After centrifugation at 14,000 rpm for 10 min at 4°C, the supernatants were 
immunoprecipitated with 0.5 g anti-IRF2 antibody, or the corresponding IgG (Sigma) (as a control), 
and Protein A Sepharose4B Fast Flow beads.  The amounts of precipitated DNA were quantified by 
PCR, using a pair of mouse Trypsinogen5 promoter-specific primers, and Angiotensinogen (Agt) 
exon2-specific primers (Materials and Methods in SI). 
Trypsin activity assay 
 Trypsin activity was monitored by the amount of released p-nitroaniline (pNA) from a 
specific substrate, measuring spectrophotometric units at 405 nm (A405) (Trypsin activity assay kit of 
BioVision).  Cell lysates prepared at 48h post-transfection of the indicated expression plasmids 
were used with or without enteropeptidase (light chain, porcine of GenScript). 
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Cell death assay 
Pancreatic tissues were used in the TUNEL assay.  Briefly, tissue sections were incubated 
with 20 g/ml proteinase K for 20 min, followed by inhibition of endogenous peroxidase by 
incubation with 2 % H2O2 for 7 min.  TdT (GIBCO-BRL) and biotinylated dUTP (Roche) in TdT 
buffer were added to the sections and incubated in a humid atmosphere at 37°C for 90 min after 
immersion in TdT buffer.  The reaction was terminated by transferring the slides to TB buffer (300 
mM NaCl, 30 mM Na citrate) for 30 min.  The sections were covered with 10% rabbit serum for 10 
min and then with the avidin-biotin peroxidase complex for 30 min.  Finally, DAB was used as the 
chromogen.  To detect the apoptotic cells, FITC-conjugated Annexin V (BioVision) was used 
according to the manufacturer’s instruction.  MTT (ICN) assay to assess living cells was performed 
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Legends for Figures 
Fig.1 IRF2 deficiency induces sensitivity to poly(I:C) and pancreatitis. A. Survival curve after 
pIC challenge.  WT and IRF2-deficient (IRF2-/-) mice were induced by intraperitoneal pIC 
challenge (250 g). All the IRF2-/- mice were deceased within a week, compared to WT mice.  B. 
Following pIC stimulation, many cells were TUNEL-positive, indicating apoptosis and severe acute 
pancreatitis, in IRF2-/- mice.  Hematoxylin and eosin (HE) staining (C) and electron microscopic 
observation (D) were done to examine the pancreas histologically in wild-type, IRF2-/-, and the 
double KO mice (IRF-2-/-IFNARI-/- , IRF-2-/-/IRF1-/-, and IRF-2-/-/TRIF-/-). E. To assess the 
pancreatitis, we monitored the serum amylase level with (+) and without (-) pIC challenge. 
 
Fig.2 Trypsinogen5 is highly expressed in IRF2-deficent mice. A, The IRF2-/-, or wild type mice 
with or without peritoneal injection of pIC were sacrificed, and the amounts of mRNA from the 
pancreas were systemically compared using Affymerix 28,815 gene probes. The points furthest from 
the diagonal indicate transcripts showing the greatest difference between the WT and IRF2-/-.  
Points 1 and 2: Trypsinogen5 with different probes; 3: -2-HS-glycoprotein (Ahsg); 4: annexin A10 
(Anxa10); 5: fetuin- (Fetub); 6: 3-hydroxy-3-methylglutaryl-CoenzymeA synthase2 (Hmgcs2, 
HMG-CoA synthase); 7: immunoglobulin kappa chain variable8 (Igk-V8); 8: unknown; 9: carbonic 
anhydrase 3 (Car3).  B. A series of deletion mutants of trypsinogen5 proximal promoter region 
(-216 to +15) were placed upstream of a luciferase reporter gene (1 g), and were analysed for 
transcriptional activity in mouse pancreatic acinar cells using a dual luciferase assay, at 24h 
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posttransfection in combination with expressions vectors (100 ng) expressing IRF5 or IRF7 or a 
control vector. The basal luciferase activity of each deletion, measured relative to the -216 to +15 
region, and the responses to IRF5 and IRF7 expression vectors were shown as fold-increase to the 
control vector. The TATA box, ISRE core, NFAT-, and AP-1-binding sites are indicated.  *p<0.05 vs. 
the -216 to +15 region. C. Point mutations were introduced in each ISRE site (indicated by x) of the 
trypsinogen5 promoters as described under Materials and Methods. The promoter activity of each 
mutant trypsinogen5 was determined with the dual luciferase assay system. *p<0.05 vs. wild type. 
 
Fig. 3 IRF-2 binds to the promoter region of trypsinogen5 gene. A. The effects of siRNAs (3 g) 
specific to IRF2 or a control scrambled sequence on transcriptional activity of the -216 to +15 
luciferase reporter in TGP49 acinar cells were measured. *p<0.05 vs. the control siRNA. B. 
Chromatin immunoprecipitation (ChIP) assay was done using TGP49 acinar cells with the 
IRF2-specific antibody (5 g), or the same amount of control non-specific IgG. The precipitated 
chromatin fragments were detected by PCR with a trypsinogen5 promoter-specific primer set at 35 
cycles, or a negative control primer set for angiotensinogen (Agt) exon2 at 30 (upper panel) and 35 
(lower panel) cycles. The input before precipitation indicates the predicted size (Trp5:289bp, 
Agt:221bp) of the PCR product. C. The ChIP assay done in B was quantitatively measured using 
real-time PCR method with the same primers. The relative amounts to -actin were calculated, and 
the amounts of chromatin fragments precipitated with the anti-IRF2 antibody were shown relative to 
those with the nonspecific control antibody (IgG). *p<0.01 vs. the control IgG. 
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Fig.4 Trypsinogen activity is activated by proteolytic cleavage. A, B. A full-length mouse 
trypsinogen5 cDNA from the mouse pancreas was cloned into pcDNA3 (Invitrogen), and expressed 
in 293T cells. The indicated amounts cell lysates (2 ~ 8 l of 5 g/l lysates) were mixed with a 
trypsin specific substrate (BioVision), in the presence or absence of added enteropeptidase (EP). 
Tryptic activity was monitored by the amount of released pNA measuring spectrophotometric units 
(A405). C, D. The effects of Spink3 were examined by adding the cell lysates expressing Spink3, a 
major intrinsic trypsin inhibitor in the mouse pancreas, to the lysates expressing trypsinogen5 (C), or 
mouse Prss1 (D). E. The DNA sequence encoding the activation peptide in the trypsinogen5 
expression vector was replaced with sequences encoding a PACE cleavage site (-RTKR-) so that the 
tryptic activity is activated by ubiquitously expressed PACE protease. F. The 293FT cells transfected 
with the PACE-trypsinogen5 or control vector were stained with FITC-labeled annexin V to detect 
apoptosis. 
 
Fig.5 Poly(I:C) and IFN treatment induces cell death through different pathways.  A. 
Viabilities of the 293FT cells transfected with the indicated expression plasmids in the presence or 
absence of pIC (5 g/ml) and IFN (50 ng/ml) for 44h were quantified with MTT assay. The values 
represent the average of at least three separate experiments with standard deviation shown by error 
bars. TRIF, and IPS-1 with MDA5 or RIG-I induced significant (*p<0.02) cell death in response to 
pIC and IFN. B. The 293FT cells transfected with TRIF expression vector or vector alone were 
stained with FITC-labeled annexin V to detect apoptosis. The mRNA expression levels of TLR3 (C), 
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RIG-I (D), and MDA5 (E) were measured using real-time PCR with (+) or without (-) intraperitoneal 
pIC injection (250 g).  The mRNAs prepared from the pancreas, liver, and spleen of wild type 
(WT), IRF2-/-, IRF2-/-/IFNAR1-/- mice were converted into cDNA, and the amount of cDNA was 
determined by real-time PCR with specific primers listed in Supplemental Table 5. The values 
represent the average of at least two mice with standard deviation shown by error bars. *p<0.05 vs. 
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Table 1.  Expressions of relevant genes to Pancreatitis 
 












Prss1 (T16, Trypsin1)  11,161  13,863 10,388  13,788 
Prss2 (T20, Trypsin 2)  16,041  15,661 15,857  15,494 
Prss3 (T11, Trypsin 3)  1,155  1,131 3,059 ↑ 2,395 
Trypsinogen5 (T4, 1810009J06Rik)  70  57 13,514 ↑ 14,287 
Chymotrypsin C (Ctrc)  545  368 87 ↓ 119 
Chymotrypsinogen B1 (Ctrb1) 19,417  18,772 20,457  19,919 
Amylase2-2, pancreatic (Amy2b) 19,101  18,488 17,092  18,261 
Calcium-sensing receptor (Casr) 37  37 30  26 
Cystic fibrosis membrane 
conductance regulator (Cftr) 
7  6 11  8 
Cathepsin B (Ctsb) 349  443 848 ↑ 794 
Serine protease inhibitor, Kazal-type3 
(Spink3)  
4,716  3,957 7,497  7,774 
Inter -trypsin inhibitor, heavy 
chain4 (Itih4) 
375  212 78 ↓ 71 
Galanin (Gal) 879  1057 213 ↓ 71   




Materials and Methods 
Reagents 
Cathepsin B (from bovine spleen) was purchased from MERCK, and 
N-(p-Tosyl)-GPK-pNA and soy bean trypsin inhibitor (SBTI) were from Sigma. 
Primers used for Real-time PCR 
The mouse -Actin primers (Forward: 5’-TGGAATCCTGTGGCATCCATGAAAC-3’, 
Reverse: 5’-TAAAACGCAGCTCAGTAACAGTCCG-3’), Trypsinogen5 primers (Forward: 
5’-ATTGAAGTCACCTGCCATCC -3’, Reverse: 5’-AGGACAGGAGCTTCCAGACA-3’), TLR3 
primers (Forward: 5’-TTGTCTTCTGCACGAACCTG-3’, Reverse: 
5’-CCCGTTCCCAACTTTGTAGA-3’), RIG-I primers (Forward: 
5’-TTGCTGAGTGCAATCTCGTC-3’, Reverse: 5’-GTATGCGGTGAACCGTCTTT-3’), and 
MDA5 primers (Forward: 5’-TGTCTTGGACACTTGCTTCG-3’, Reverse: 
5’-GGCCTCTGTCTCCAGACTTG-3’), were used for real-time PCR. 
Primers used for ChIP assay 
The mouse IRF2 promoter-specific primers (Forward: 
5’-CCGGGGGAAACAATGATGTGGAAAC-3’, Reverse: 5’-AGCAGCTCCCAGAAAAGTGA-3’), 
and Angiotensinogen (Agt) exon2-specific primers (Forward: 5’-CACCCCTGCTACAGTCCATT-3’, 





1: Bhandari M, Thomas AC, Hussey D-J, Li X, Jaya SP, et al (2010) Galanin mediates the 
pathogenesis of cerulein-induced acute pancreatitis in the mouse. Pancreas 39:182-187. 
 
Legends for Figures 
Supplemental Fig. S1  Resistance of IRF-2-/- mice to cerulein-induced pancreatitis. Wild-type or 
IRF-2-/- mice were injected intraperitoneally with 50 g/kg Cerulein 6 times at hourly intervals.  
One hour after the last injection, the pancreas was subjected to electron microscopic analysis (A), 
and their serum amylase levels were also measured (B). Bar indicates 5 m. C. The pancreatic 
mRNAs of WT and IRF2-/- mice were prepared by the method of acid guanidium 
thiocyanate-phenol-chloroform extraction after treated with RNALater (Ambion) for overnight at 
-80°C, and the expressions of CCK-AR, and CCK-BR were analyzed by Northern blotting with the 
radio-labeled specific probes. The -actin expression was shown as control. 
 
Supplemental Fig. S2  A. The schematic structures of mouse trypsinogen genes in the T cell 
receptor -chain (TRB) locus. Twenty trypsinogen genes (T1~T20) are found in mouse, but only 12 
of them are thought to be expressed, as indicated by filled arrows. The mouse Trb v, d, j genes are 
shown as open arrows. B. The evolutional pedigree of three human trypsinogens and 12 mouse 
trypsinogens.  Human PRSS1, 2, 3 and mouse Prss1, 2, and 3, and trypsinogen5 are boxed. The 
pedigree was made using the UPGMA (Unweighted Pair-Group Method with Arithmatic mean) 
method. The associated number calculated by this method indicates the evolutional distance, such 
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that smaller values are more homologous and evolutionarily closer to each other, whereas larger 
values are less homologous and evolutionarily more distant. 
 
Supplemental Fig. S3  A. The trypsinogen5 mRNA expression levels in indicated tissues were 
normalized to -actin expression, and are shown on a log scale. It was expressed at low but 
accurately measurable levels in the wild-type pancreas and skin, compared to the spleen, liver, and 
lung. The trypsinogen5 mRNA expressions in pancreas and spleen were up-regulated about 
1,000-fold in the IRF2-/- mice compared to the wild-type. However, the up-regulations were not 
affected by further abolishing the IFNAR1. B. The promoter activity of trypsinogen5 was examined 
by placing the 1.1 kb trypsinogen5 promoter region before the Firefly luciferase gene, as reporter in 
293T cells. The expression vectors for IRF1, 2, 3, 5, and 7 were co-transfected with the reporter, in 
the presence or absence of MyD88. The luciferase activity was determined with the dual luciferase 
assay system. IRF1, 5, and 7 enhanced significantly (*p<0.02) the trypsinogen5 promoter in the 
presence of MyD88. C. The promoter activities of deletion mutants of trypsinogen5 promoter were 
measured in the absence or presence of both Myd88, and IRF1 or IRF7 in 293T cells. D. The 
dose-dependent effects of IRF2 expression on the IRF1- and IRF7-dependent trypsinogen5 promoter 
activations in the presence of MyD88. *p<0.02 vs. the absence of IRF2. 
 
Supplemental Fig. S4  The amino acid sequences of major human trypsinogens (PRSS1, 2, and 3), 
and mouse Prss1, 2, and 3, and trypsinogen5 are aligned. The signal peptidase, enteropeptidase, and 
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chymotrypsin C cleavage sites are indicated with arrows, and the trypsin autolytic cleavage site is 
indicated with an arrow head. Active trypsin is generated from trypsinogen, by cleavage at the signal 
peptide in the endoplasmic reticulum, and at activation peptide in the duodenum. Since mouse 
trypsinogen5 contains the triad (H-D-S) of amino acids essential for the trypsin activity (each amino 
acid indicated with *), a signal peptide and an activation peptide in the N-terminal region, this 
trypsinogen5 is predicted to have enzymatic activity. The inhibitor binding site D198 is unique in the 
trypsinogen5, and may confer resistance to trypsin inhibitors, similar to human PRSS3, R198. The 
conserved amino acids are boxed. 
 
Supplemental Fig. S5 Trypsin activity was monitored by the amount of released p-nitroaniline 
(pNA) from a specific substrate, measuring spectrophotometric units at 405 nm (A405) (Trypsin 
activity assay kit of BioVision). The activities were dependent on the addition of enteropeptidase 
(EP), and increased in proportion to the amounts of lysates added to the reaction. Addition of 1, and 
2 g/ml soy bean trypsin inhibitor (SBTI), had no effect on the mouse trypsinogen5 activities 
observed (A). In contrast, the mouse Prss1 activities were inhibited with (SBTI), in a dose-dependent 
fashion (B). C. Activation of trypsinogen5 with cathepsin B. The same amounts of 293FT cell lysates 
transfected with mouse trypsinogen5 (Tryp5) or vector only (Vector) were pretreated with 0.008 
units of cathepsin B (CB) in 50 mM acetic acid buffer (pH5.0) for 2h at 37°C, and then subjected to 
trypsin assay using N-(p-Tosyl)-GPK-pNA as substrate in 100 mM Tris buffer (pH8.0) at 30°C for 





Supplemental Fig. S6 Pathways for synthetic double-strand RNA (dsRNA), poly(I:C)-dependent 
signal transductions in WT (A) and in IRF2-/- (B) mice. The IRF2-/- pancreatic acinar cells 
susceptible to pancreatitis are loaded with a large number of zymogen granules, including 
Trypsinogen5, expressed by transcriptional activation by IRF5 and IRF7. pIC induces type I IFN 
production (I-IFN) and the I-IFN activates transcriptions of ISGs including MDA5, RIG-I, and TLR3. 
The increased MDA5, RIG-I, and TLR3, induce cell death via IPS-1, and TRIF. The leaked 
Trypsinogen5 from dying acinar cells, is activated to Trypsin5 by released proteases such as 
cathepsinB, or nearby enteropeptidase. Cell death is exacerbated since the Trypsin5 is resistant to the 
major pancreatic trypsinogen inhibitor, Spink3. The cell death amplification (enhancing loop) leads 
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hPRSS1.p.gpt 1 MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGY-HFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFIN 89
hPRSS2.p.gpt 1 MNLLLILTFVAAAVAAPFDDDDKIVGGYICEENSVPYQVSLNSGY-HFCGGSLISEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFIN 89




mPrss1.p.gpt 1 MSALLFLALVGAAVAFPVDDDDKIVGGYTCRENSVPYQVSLNSGY-HFCGGSLINDQWVVSAAHCYKTRIQVRLGEHNINVLEGNEQFID 89
mPrss2.p.gpt 1 MSALLILALVGAAVAFPVDDDDKIVGGYTCRESSVPYQVSLNAGY-HFCGGSLINDQWVVSAAHCYKYRIQVRLGEHNINVLEGNEQFVD 89
mPrss3.p.gpt 1 MNALLILALVGAAVAFPVDDDDKIVGGYTCQENSVPYQVSLNSGY-HFCGGSLINDQWVVSAAHCYKTRIQVRLGEHNINVLEGNEQFVN 89
mTrypsinogen5.p.gpt 1 MKIITFFTFLGAAVALPANSDDKIVGGYTCPKHSVPYQVSLNDGISHQCGGSLISDQWVLSAAHCYKRRLQVRLGEHNIDVLEGGEQFID 90
hPRSS1 p gpt 90 AAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTA-PPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGK 178. .
hPRSS2.p.gpt 90 AAKIIRHPKYNSRTLDNDILLIKLSSPAVINSRVSAISLPTA-PPAAGTESLISGWGNTLSSGADYPDELQCLDAPVLSQAECEASYPGK 178
hPRSS3.p.gpt 90 AAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTA-PPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGK 178
mPrss1.p.gpt 90 AAKIIKHPNFNRKTLNNDIMLIKLSSPVTLNARVATVALPSSCAPA-GTQCLISGWGNTLSFGVSEPDLLQCLDAPLLPQADCEASYPGK 178
mPrss2.p.gpt 90 SAKIIRHPNYNSWTLDNDIMLIKLASPVTLNARVASVPLPSSCAPA-GTQCLISGWGNTLSNGVNNPDLLQCVDAPVLPQADCEASYPGD 178
mPrss3.p.gpt 90 AAKIIKHPNFNRKTLNNDIMLLKLSSPVTLNARVATVALPSSCAPA-GTQCLISGWGNTLSFGVSEPDLLQCLDAPLLPQADCEASYPGK 178
*
mTrypsinogen5.p.gpt 91 AEKIIRHPDYNKDTVDNDIMLIKLKSPAILNSQVSTVSLPRSCAST-NAQCLVSGWGNTVSIGGKYPALLQCLEAPVLSASSCKKSYPGQ 179
hPRSS1.p.gpt 179 ITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS 247
hPRSS2.p.gpt 179 ITNNMFCVGFLEGGKDSCQGDSGGPVVSNGELQGIVSWGYGCAQKNRPGVYTKVYNYVDWIKDTIAANS 247
hPRSS3.p.gpt 179 ITNSMFCVGFLEGGKDSCQRDSGGPVVCNGQLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAANS 247
mPrss1.p.gpt 179 ITGNMVCAGFLEGGKDSCQGDSGGPVVCNGELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN- 246
mPrss2.p.gpt 179 ITNNMICVGFLEGGKDSCQGDSGGPVVCNGELQGIVSWGYGCAQPDAPGVYTKVCNYVDWIQNTIADN- 246
mPrss3.p.gpt 179 ITGNMVCAGFLEGGKDSCQGDSGGPVVCNRELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIAAN- 246




































































































    WT 
    (-) 
   WT 








Trypsinogen 5 (1810009J06Rik) 80 69 14345 15470 
Fetuin  (Fetub) 14 15 926 1623 
3-Hydroxy-3-methylglutaryl-Coenzyme A synthase 2 
(Hmgcs2, HMG-CoA synthase) 
23  240  1375  777  
Annexin A10 (Anxa10) 11 11 647 427 
Ep1 (epithelial progenitor 1) 10 12 303 111 
Lectin, galactose binding, soluble 9 (Lgals9) 90 625 1369 1629 
-2-HS-glycoprotein (Ahsg, Fetuin-A)  10 12 157 591 
Transmembrane 4 superfamily member 4  
(Tm4sf4) 
58  64  783  349  
Guanylate binding protein 2 (Gbp2)  22 1064 258 1230 
regenerating islet-derived 3 (Reg3g)  268 4511 2756 2758 
Macrophage activation 2 like (Gbp6, guanylate 
binding protein 6)  
17  177  174  349  
Lipocalin 2 (Lcn2) 28  146  283  217  
Group specific component 
(Gc, Vitamin D-binding protein) 
30 21 186 577 
S100 calcium binding protein G (S100-G) 58  19  114  252  
Immunoglobulin kappa chain variable 8 (Igk-V8) 25  455  24  7  
Carbonic anhydrase 3 (Car3) 152  1301  103  49  
Complement factor D (adipsin)  157  707  56  38  
Immunoglobulin joining chain (Igj) 30  168  25  11  
Galanin (Gal)  879  1057  213  71  
Cxcl13 (chemokine (C-X-C motif) ligand 13)  82  806  29  60  
Immunoglobulin lambda variable 1 (Iklv1)  18  147  25  14  
Solute carrier family 38, member 5 (Slc38a5) 1533  1683  143  196  
Upper fourteen annotated genes were up-regulated more than 10-fold in IRF2-/- mouse. 
The up-regulation of trypsinogen 5 more than one hundred-fold by inactivating IRF2 
gene was noteworthy, because trypsinogens are reported to play important roles to 
develop pancreatitis.  The three Ca2+-binding proteins are also highlighted. Lower 
eight genes were down-regulated more than 10-fold in IRF2-/- mouse.  Galanin is 
reported to mediate the Cerulein-induced pancreatitis (1). 
Supplemental Table S2.  Expressions of IFN-signaling molecules 
(Affymetrix unit) 
 
Genes    WT 











IRF1 35  286 ↑ 44  361 ↑ 
IRF3 97 113 136 114 
IRF4 19 16 10 15 
IRF5 34 47 36 46 
IRF6 114 148 197 171 
IRF7 26 375 ↑ 107 224 ↑ 
IRF8 32 81 43 54 
IRF9 44 191 88 237 
IPS-1 109 113 121 123 
TRIF  53 55 51 53 
MyD88  31 311 ↑ 77 297 ↑ 
TIRAP  23 46 36 47 
MDA5 35 921 ↑ 76 733 ↑ 
RIG-I 47 538 ↑ 93 458 ↑ 
TLR1 9 9 10 6 
TLR2 55 151 55 133 
TLR3 13 98 ↑ 24 118 ↑ 
TLR4 20 26 26 27 
TLR6 15 18 14 12 
TLR7 6 21 16 12 
TLR8 8 9 10 9 
TLR9 42 80 40 36 
The DNA microarray analysis indicated that IRF1, IRF7, MyD88, MDA5, 
RIG-I, and TLR3 were significantly up-regulated with the poly(I:C) in the 
pancreas of IRF2-/- mice.  
 
Supplemental Table S3.  Relationship among relevant gene expressions, cell death, 
and pancreatitis 
 












Granule retention - - +++ +++ +++ +++ +++ +++ 
Trypsinogn5 - - +++ +++ +++ +++ +++ +++ 
TLR3/TRIF + +++ + +++ + + - - 
MDA5/RIG-I/IPS-1 + +++ + +++ + + + +++ 
Cell death - + - + - - - + 
Enhanced cell death - - - +++ - - - + 
Pancreatitis - - - +++ - - - + 
Serum amylase - - - +++ - - - + 
 
IRF2-/- caused abnormal granule retention (+++), and conspicuous expression of 
Trypsinogen5 (+++), and the characteristics were not rescued by further destroying 
IFNAR1 or TRIF.  There were at least two cell death pathways; the TLR3/TRIF and 
the MDA5/RIG-I/IPS-1, and the high expressions of TLR3/TRIF or 
MDA5/RIG-I/IPS-1 (+++) caused cell death. In addition, high expressions of 
spink3-resistant trypsinogen5 (+++) are required for the enhanced the enhanced cell 
death led to pancreatitis with elevated serum amylase (+++). 
 
